Comment on

• Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial.

  Duffy SW, Vulkan D, Cuckle H, Parmar D, Sheikh S, Smith RA, Evans A, Blyuss O, Johns L, Ellis IO, Myles J, Sasieni PD, Moss SM. Duffy SW, et al. Lancet Oncol. 2020 Sep;21(9):1165-1172. doi: 10.1016/S1470-2045(20)30398-3. Epub 2020 Aug 12. Lancet Oncol. 2020. PMID: 32800099 Free PMC article. Clinical Trial.
• Mammography screening for breast cancer-the UK Age trial.

  Bell KJL, Irwig L, Nickel B, Hersch J, Hayen A, Barratt A. Bell KJL, et al. Lancet Oncol. 2020 Nov;21(11):e504. doi: 10.1016/S1470-2045(20)30528-3. Lancet Oncol. 2020. PMID: 33152296 No abstract available.
• Mammography screening for breast cancer-the UK Age trial.

  Al-Shamsi HO. Al-Shamsi HO. Lancet Oncol. 2020 Nov;21(11):e505. doi: 10.1016/S1470-2045(20)30492-7. Lancet Oncol. 2020. PMID: 33152297 No abstract available.
• Mammography screening for breast cancer-the UK Age trial.

  Jatoi I. Jatoi I. Lancet Oncol. 2020 Nov;21(11):e506. doi: 10.1016/S1470-2045(20)30550-7. Lancet Oncol. 2020. PMID: 33152298 No abstract available.
• Mammography screening for breast cancer-the UK Age trial.

  Gera R, Michell MJ, Mokbel K. Gera R, et al. Lancet Oncol. 2020 Nov;21(11):e507. doi: 10.1016/S1470-2045(20)30491-5. Lancet Oncol. 2020. PMID: 33152299 No abstract available.
• Mammography screening for breast cancer-the UK Age trial.

  Narod SA. Narod SA. Lancet Oncol. 2020 Nov;21(11):e508. doi: 10.1016/S1470-2045(20)30490-3. Lancet Oncol. 2020. PMID: 33152300 No abstract available.
• Mammography screening for breast cancer-the UK Age trial.

  Donzelli A, Giudicatti G, Sghedoni D. Donzelli A, et al. Lancet Oncol. 2020 Nov;21(11):e509. doi: 10.1016/S1470-2045(20)30631-8. Lancet Oncol. 2020. PMID: 33152301 No abstract available.